Therapeutic and Adverse Effects of a Non-Steroidal Glucocorticoid Receptor Ligand in a Mouse Model of Multiple Sclerosis

Simone Wüst, Denise Tischner, Michael John et al. · 2009

Read Therapeutic and Adverse Effects of a Non-Steroidal Glucocorticoid Receptor Ligand in a Mouse Model of Multiple Sclerosis by Simone Wüst, Denise Tischner, Michael John et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008202.txt.

Description

Simone Wüst and colleagues tested a new steroid-like drug in mice in a PLOS ONE study from 2009. The drug targets the glucocorticoid receptor, a switch for inflammation. Classic steroids help many disorders but cause harsh side effects. A dissociating ligand aims to keep the benefit while avoiding the harm. That split rests on two modes of receptor action.

The team challenged that hope in a mouse model of multiple sclerosis. They measured both healing effects and adverse effects of the ligand. The results test whether benefit and harm can truly be separated. The answer matters for safer anti-inflammatory drugs.

Catalog record

CREATORSimone Wüst, Denise Tischner, Michael John et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008202

Browse the full library · About the Tower of Babel